Ironwood Pharmaceuticals (IRWD) PT Trimmed at Wedbush on Positive Data from Competitor Synergy (SGYP)
Tweet Send to a Friend
Wedbush analyst David Nierengarten reiterated a Neutral rating and lowered his price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $11.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
